PMPs in clinical trials and advanced PMIPs - Research findings first presented at FinMed 2006, on 30th March 2006 - table last updated Oct.07

with thanks to Francois Arcand and Dr Ulrich Steiner - © Brian Marshall, MolecularFarming.com - 2006 g

- What is bookmarking and how does it help other people?

Research findings summary
1] From 1995 - 2006 the total amount of land used for every PMP trial done outdoors was less than 1200 acres ( an average US farm)
2] By 2015 - even with 40 approved PMP drugs with $1bn markets each, land use will be less than 40,000 acres - less than 50 farms.
3] Molecular Farming of PMPs is "pharmaceutical gardening", and has little in common with food agriculture
4] PMIPs have the potential to have more significant land use than PMPs - eventually.
5] On examination of PMIP products and regulation stage achieved so far, major growing in the 1,000,000+ acres scale is extremely unlikely in the next 6 to 8 years. ( Molecular Farming of PMIPs will not be comparable to any major Global food / feed / fibre production in the medium term )

During my research I have found that PMPs are in development for almost all major human diseases and conditions, including
Alzheimer's disease , Anthrax, Arthritis , Cancer, Chronic obstructive pulmonary disorder (COPD), Crohn's disease, Cystic Fibrosis, Diabetes, Heart Disease, Hepatitis B, Hepatitis C, HIV, Iron deficiency, Kidney Disease, Measles, Multiple sclerosis, Obesity, SARS and Spinal Cord Injuries.
Animal / poultry vaccines and medicines are also in development for diseases like Avian flu, Coccidiosis, Fowl pest, Parvovirus and Rabies

Permission is granted by Brian Marshall and MolecularFarming.com, to reprint or reproduce this work for any non-profit use, provided that the original source and author's name is included in the reproduction.
Reproducing any or all of this work for profit, without written permission of the author, will be taken as breach of copyright.